LY-4060874
- Generic Name
- LY-4060874
A Study of LY4060874 in Healthy Participants
- First Posted Date
- 2024-11-29
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 132
- Registration Number
- NCT06709820
- Locations
- 🇺🇸
Fortrea, Inc., Dallas, Texas, United States
🇸🇬Lilly Centre for Clinical Pharmacology, Singapore, Singapore
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath